Original ResearchPulmonary Vascular DiseaseFeaturedOral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial
2012
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
155
Citations
NaN
KQI